Sarah Otten

VP, GM Medison Americas


“I have a great passion for the Americas region, and I am excited about the opportunity to make advanced therapies accessible, changing the lives of so many patients in need by utilizing Medison’s truly distinctive and innovative platform.”

Sarah is the company’s VP, GM of Medison Americas, leading Medison’s operations and activities in the Americas region. With a focus on continued advancement and growth, Sarah also spearheads strategic development, marketing, and strengthening of partnerships in the region.

Prior to joining Medison, Sarah held the position of VP Global Market Access and Commercial Strategy at Apellis Pharmaceutical, where she successfully implemented market access strategies and drove business growth. Previously, she held senior roles in Commercial and Corporate Compliance at Vertex Pharmaceuticals, including Executive Director of Global Geographic Expansion and Head of Latin America.

Sarah holds a BA in Psychology and Criminology from the University of New Mexico,. She also holds an MBA from Keller Graduate School of Management, DeVry University.